Compare Godaddy Inc (GDDY) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Twist Bioscience Corp — how do they compare? Godaddy Inc trades at $105.26 (market cap $13.07B), while Twist Bioscience Corp trades at $163.14 (market cap $10.08B). The key difference: Godaddy Inc is the larger of the two by market cap, and Twist Bioscience Corp is trading nearer its 52-week high, Godaddy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Twist Bioscience Corp for 27 Days on average.
| GDDY | TWST | |
|---|---|---|
Market Cap | $13.07B | $10.08B |
Volume | 1,831,274 | 4,229,037 |
Sector | Technology | Health |
52-Week High | $135.18 | $205.00 |
52-Week Low | $75.07 | $25.45 |
Typical Hold Time | 65 Days | 27 Days |
Enterprise Value | $15.75B | $10.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $97.21, down 0.99% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company shows strong profitability with 63.8% gross margins and has beaten earnings estimates for three consecutive quarters. Revenue growth continues steadily from $4.95B in 2025 to projected $5.1B in 2026. Analyst consensus remains positive with 57.9% buy ratings and a $96.20 price target, though the stock faces headwinds from multiple securities class action lawsuits alleging misleading disclosures about domain pricing strategies.
The outlook remains cautiously optimistic given strong fundamentals and earnings momentum, but legal risks from ongoing securities litigation present significant near-term uncertainty. Investors should weigh the company's solid operational performance against potential legal liabilities and stock price volatility stemming from the class action proceedings with October 2026 deadlines.
TWST trades at $155.65, down 6.78% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $377M in 2025, but the company remains unprofitable with a net income margin of -31.66%. Recent news highlights its role in Eli Lilly's AI-driven drug discovery platform, boosting sentiment despite earnings misses.
The outlook is mixed: analyst consensus is bullish with a $145.20 price target, but high valuation multiples and persistent losses pose risks. Investment opportunity hinges on AI partnerships driving future profitability, while execution risks and cash burn require careful monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
